Discontinued — last reported Q3 '25
Sachem Capital Corp. Total Revenue increased by 11.4% to $12.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 18.8%, from $14.79M to $12.00M. Over 3 years (FY 2021 to FY 2024), Total Revenue shows an upward trend with a 23.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.71M | $8.52M | $9.48M | $10.30M | $12.55M | $13.54M | $15.89M | $14.71M | $16.27M | $17.78M | $16.41M | $16.80M | $15.15M | $14.79M | $10.77M | $11.44M | $10.78M | $12.00M |
| QoQ Change | — | +26.9% | +11.2% | +8.7% | +21.8% | +7.9% | +17.3% | -7.4% | +10.6% | +9.2% | -7.7% | +2.4% | -9.9% | -2.4% | -27.2% | +6.3% | -5.8% | +11.4% |
| YoY Change | — | — | — | — | +86.9% | +58.9% | +67.6% | +42.8% | +29.7% | +31.3% | +3.3% | +14.2% | -6.9% | -16.8% | -34.4% | -31.9% | -28.9% | -18.8% |